Tokyo Tape
Sign in
← Sakai Chemical Industry

Quarterly report · Q3

4078.TEDINET S100THLQ
Period2023-04-01 → 2023-12-31
Filed2024-05-27
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed

Amends S100ST22.

Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥60.8bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥83.9bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥63.8bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥1.7bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥4.2bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥1.8bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥4.9bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥4.7bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax−¥4.5bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥5.0bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)−¥7.5bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.3bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.4bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income−¥7.2bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥3.6bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥123.7bnat 2023-12-31Cons.Assets
Total assets¥128.0bnat 2023-03-31Cons.Assets
Total assets¥131.3bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥48.9bnat 2023-12-31Cons.Liabilities
Total liabilities¥43.3bnat 2023-03-31Cons.Liabilities
Net assets / equity¥74.7bnat 2023-12-31Cons.Net assets
Net assets / equity¥84.7bnat 2023-03-31Cons.Net assets
Net assets / equity¥85.7bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥13.6bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥12.4bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥-460.962023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-335.432023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥144.852022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥207.792022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.312022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio59.5%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio62.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio62.0%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥907m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥907m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥1.7bn
jpcrp040300-q3r_E00780-000Chemicalreportable segmentrevenue2023-04-01 → 2023-12-31¥55.1bn
jpcrp040300-q3r_E00780-000Chemicalreportable segmentrevenue external2023-04-01 → 2023-12-31¥54.4bn
jpcrp040300-q3r_E00780-000Chemicalreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥726m
jpcrp040300-q3r_E00780-000Chemicalreportable segmentsegment profit2023-04-01 → 2023-12-31¥3.1bn
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentrevenue2023-04-01 → 2023-12-31¥6.5bn
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentrevenue external2023-04-01 → 2023-12-31¥6.4bn
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥181m
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentsegment profit2023-04-01 → 2023-12-31¥260m
—segment totalrevenue2023-04-01 → 2023-12-31¥61.7bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥60.8bn
—segment totalrevenue intersegment2023-04-01 → 2023-12-31¥907m
—segment totalsegment profit2023-04-01 → 2023-12-31¥3.4bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥808m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥808m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥1.7bn
jpcrp040300-q3r_E00780-000Chemicalreportable segmentrevenue2022-04-01 → 2022-12-31¥58.1bn
jpcrp040300-q3r_E00780-000Chemicalreportable segmentrevenue external2022-04-01 → 2022-12-31¥57.5bn
jpcrp040300-q3r_E00780-000Chemicalreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥575m
jpcrp040300-q3r_E00780-000Chemicalreportable segmentsegment profit2022-04-01 → 2022-12-31¥5.5bn
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentrevenue2022-04-01 → 2022-12-31¥6.5bn
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentrevenue external2022-04-01 → 2022-12-31¥6.3bn
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥233m
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentsegment profit2022-04-01 → 2022-12-31¥394m
—segment totalrevenue2022-04-01 → 2022-12-31¥64.6bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥63.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥808m
—segment totalsegment profit2022-04-01 → 2022-12-31¥5.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 376
ItemContextValueUnit
Foreign currency translation adjustmentPrior1YearInstant253000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant730000000JPY
Remeasurements of defined benefit plansPrior1YearInstant117000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant105000000JPY
Valuation and translation adjustmentsPrior1YearInstant1624000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant2804000000JPY
Subscription rights to sharesPrior1YearInstant－JPY
Subscription rights to sharesCurrentQuarterInstant35000000JPY
Non controlling interestsPrior1YearInstant4229000000JPY
Non controlling interestsCurrentQuarterInstant1077000000JPY
Net assetsPrior1YearInstant84717000000JPY
Net assetsCurrentQuarterInstant74722000000JPY
Liabilities and net assetsPrior1YearInstant128021000000JPY
Liabilities and net assetsCurrentQuarterInstant123665000000JPY
Net salesPrior1YTDDuration63759000000JPY
Net salesCurrentYTDDuration60755000000JPY
Cost of salesPrior1YTDDuration48967000000JPY
Cost of salesCurrentYTDDuration48594000000JPY
Gross profitPrior1YTDDuration14792000000JPY
Gross profitCurrentYTDDuration12160000000JPY
Selling general and administrative expensesPrior1YTDDuration10609000000JPY
Selling general and administrative expensesCurrentYTDDuration10455000000JPY
Operating incomePrior1YTDDuration4182000000JPY
Operating incomeCurrentYTDDuration1705000000JPY
Interest income noiPrior1YTDDuration3000000JPY
Interest income noiCurrentYTDDuration8000000JPY
Dividends income noiPrior1YTDDuration141000000JPY
Dividends income noiCurrentYTDDuration143000000JPY
Insurance income noiPrior1YTDDuration2000000JPY
Insurance income noiCurrentYTDDuration168000000JPY
Foreign exchange gains noiPrior1YTDDuration403000000JPY
Foreign exchange gains noiCurrentYTDDuration231000000JPY
Other noiPrior1YTDDuration58000000JPY
Other noiCurrentYTDDuration51000000JPY
Non operating incomePrior1YTDDuration608000000JPY
Non operating incomeCurrentYTDDuration602000000JPY
Interest expenses noePrior1YTDDuration55000000JPY
Interest expenses noeCurrentYTDDuration86000000JPY
Tender offer related costs noePrior1YTDDuration－JPY
Tender offer related costs noeCurrentYTDDuration357000000JPY
Other noePrior1YTDDuration45000000JPY
Other noeCurrentYTDDuration87000000JPY
Non operating expensesPrior1YTDDuration101000000JPY
Non operating expensesCurrentYTDDuration530000000JPY
Ordinary incomePrior1YTDDuration4689000000JPY
Ordinary incomeCurrentYTDDuration1777000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration4000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration0JPY
Gain on sales of investment securities eiPrior1YTDDuration85000000JPY
Gain on sales of investment securities eiCurrentYTDDuration69000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass